Skip to main content

TOKYO, Published date 13 January, 2016

Hitachi Announces Changes in the Method of the Reorganization of Hitachi Medical and Hitachi Aloka Medical and the Execution of Absorption-type Company Split Agreement

Tokyo, January 13, 2016 --- Hitachi, Ltd. (TSE:6501, “Hitachi”), Hitachi Medical Corporation (“Hitachi Medical”), and Hitachi Aloka Medical, Ltd. (“Hitachi Aloka Medical”) announced on July 21, 2015, that a decision had been made regarding the absorption-type merger of Hitachi Medical and Hitachi Aloka Medical by Hitachi, and the establishment of a manufacturing subsidiary, as part of efforts to strengthen the healthcare business. After that, as a result of further consideration on the optimum business operation structure, etc., they today agreed to transfer non-manufacturing divisions (e.g., sales and planning divisions; the “Divisions to Be Transferred”) from Hitachi Medical and Hitachi Aloka Medical to Hitachi through an absorption-type company split (the “Company Split) and to conduct an absorption-type merger of Hitachi Aloka Medical by Hitachi Medical after the Company Split. They also today executed an absorption-type company split agreement (the “Absorption-type Company Split Agreement”).